Our scientist participated in the 5-th Annual IIR Protein Kinase Congress (July 04-05, 2006, Zurich, Switzerland). At the conference, a joint research project on co-crystalization of our newly developed quinolone inhibitors and human CK2 was initiated. Our Department represenred poster "EVALUATION OF 3-CARBOXY-4-(1H)-QUINOLONES AS INHIBITORS OF HUMAN PROTEIN KINASE CK2"